These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 34866084)

  • 61. [MYC gene amplification attributed to double minutes in a patient with atypical chronic myeloid leukemia].
    Okamoto Y; Tabata S; Shibata S; Takiuchi Y; Yamamoto K; Aiba A; Kitano T; Arima N
    Rinsho Ketsueki; 2019; 60(11):1538-1543. PubMed ID: 31839631
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Neutrophilic progression in a case of polycytemia vera mimicking chronic neutrophilic leukemia: clinical and molecular characterization.
    Castelli R; Cugno M; Gianelli U; Pancrazzi A; Vannucchi AM
    Pathol Res Pract; 2015 Apr; 211(4):341-3. PubMed ID: 25480691
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Atypical chronic myeloid leukemia in a German Shepherd Dog.
    Marino CL; Tran JNSN; Stokol T
    J Vet Diagn Invest; 2017 May; 29(3):338-345. PubMed ID: 28205462
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Genetic Response of Chronic Neutrophilic Leukemia With CSF3R T618I, SETBP1, and ASXL1 Mutations After Decitabine Therapy.
    Cao S; Tao Q; Wang J; Zhang Q; Dong Y
    Am J Ther; 2024 Sep-Oct 01; 31(5):e550-e552. PubMed ID: 39292831
    [No Abstract]   [Full Text] [Related]  

  • 65. Outgrowth of a CSF3R-mutant clone drives a second myeloproliferative neoplasm in a chronic myeloid leukemia patient: a case report.
    Carratt SA; Brewer D; Maxson JE; Druker BJ; Braun TP
    Biomark Res; 2021 Jan; 9(1):8. PubMed ID: 33516272
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Chronic neutrophilic leukaemia.
    Uppal G; Gong J
    J Clin Pathol; 2015 Sep; 68(9):680-4. PubMed ID: 26082513
    [TBL] [Abstract][Full Text] [Related]  

  • 67. CSF3R T618I, ASXL1 G942 fs and STAT5B N642H trimutation co-contribute to a rare chronic neutrophilic leukaemia manifested by rapidly progressive leucocytosis, severe infections, persistent fever and deep venous thrombosis.
    Luo Q; Shen J; Yang Y; Tang H; Shi M; Liu J; Liu Z; Shi X; Yi Y
    Br J Haematol; 2018 Mar; 180(6):892-894. PubMed ID: 27984641
    [No Abstract]   [Full Text] [Related]  

  • 68. [Novel method in diagnosis of chronic myeloproliferative disorders--detection of JAK2 mutation].
    Rajnai H; Bödör C; Reiniger L; Timár B; Csernus B; Szepesi A; Csomor J; Matolcsy A
    Orv Hetil; 2006 Nov; 147(45):2175-9. PubMed ID: 17402211
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Myeloproliferative Neoplasm or Reactive Process? A Rare Case of Acute Myeloid Leukemia and Transient Posttreatment Megakaryocytic Hyperplasia with JAK-2 Mutation.
    Wang S; Yan J; Zhou G; Heintzelman R; Hou JS
    Case Rep Hematol; 2016; 2016():6054017. PubMed ID: 27752371
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Unpaired Extracellular Cysteine Mutations of CSF3R Mediate Gain or Loss of Function.
    Zhang H; Means S; Schultz AR; Watanabe-Smith K; Medeiros BC; Bottomly D; Wilmot B; McWeeney SK; Kükenshöner T; Hantschel O; Tyner JW
    Cancer Res; 2017 Aug; 77(16):4258-4267. PubMed ID: 28652245
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Atypical chronic myeloid leukemia as defined in the WHO classification is a JAK2 V617F negative neoplasm.
    Fend F; Horn T; Koch I; Vela T; Orazi A
    Leuk Res; 2008 Dec; 32(12):1931-5. PubMed ID: 18555525
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Inherited transmission of the CSF3R T618I mutation: a familial report.
    Serin I; Cinli TA; Tunc S; Kaynar L; Sevindik OG; Yokus O
    Ann Hematol; 2023 Feb; 102(2):477-479. PubMed ID: 36376598
    [No Abstract]   [Full Text] [Related]  

  • 73. CSF3R P733T is a deleterious germline variant in acute leukaemia showing gain-of-function-like T618I mutation.
    Sun H; Zhu Y; Li J; Zhao L; Yan Z; Zhang S
    Br J Haematol; 2024 Mar; 204(3):e31-e33. PubMed ID: 38262633
    [No Abstract]   [Full Text] [Related]  

  • 74.
    Kwon A; Ibrahim I; Le T; Jaso JM; Weinberg O; Fuda F; Chen W
    Leuk Res Rep; 2022; 17():100323. PubMed ID: 35586707
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Colony Stimulating Factor 3 Mutations and Myeloid Malignancies.
    Xing Y; Zhao MF
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2016 Feb; 38(1):103-7. PubMed ID: 26956865
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Genetically informed therapy in leukemia.
    Radich J
    N Engl J Med; 2013 May; 368(19):1838-9. PubMed ID: 23656651
    [No Abstract]   [Full Text] [Related]  

  • 77. Hereditary chronic neutrophilic leukemia in a four-generation family without transformation to acute leukemia.
    Lance A; Chiad Z; Seegers SL; Paschall SC; Drummond K; Steuerwald NM; Yang HT; Chen J; Voorhees PM; Avalos BR; Druhan LJ
    Am J Hematol; 2024 Oct; 99(10):1877-1886. PubMed ID: 38934467
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Role of CSF3R mutations in the pathomechanism of congenital neutropenia and secondary acute myeloid leukemia.
    Klimiankou M; Mellor-Heineke S; Zeidler C; Welte K; Skokowa J
    Ann N Y Acad Sci; 2016 Apr; 1370(1):119-25. PubMed ID: 27270496
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Leukemia Cell Lines: In Vitro Models for the Study of Chronic Neutrophilic Leukemia.
    Drexler HG; Nagel S; Quentmeier H
    Curr Oncol; 2021 May; 28(3):1790-1794. PubMed ID: 34068566
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Chronic Neutrophilic Leukemia: A Case Report of a Rare Myeloproliferative Neoplasm With a
    Coombs LA
    J Adv Pract Oncol; 2019; 10(8):853-857. PubMed ID: 33425468
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.